N. Ghazzar

Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial

Valérie Vilgrain, Héléna Pereira, Eric Assenat et al. · The Lancet Oncology · 2017 · 826 citations

Medicine, Oncology, Radiation Oncology +16

Accuracy of 18-Fluoro-2-deoxy-d-glucose Positron Emission Tomography in the Pretherapeutic Detection of Occult Para-aortic Node Involvement in Patients with a Locally Advanced Cervical Carcinoma

Éric Leblanc, H. Gauthier, Denis Querleu et al. · Annals of Surgical Oncology · 2011 · 117 citations

Medicine, Oncology, Radiology +15

Limited screening with versus without 18F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial

Philippe Robin, Pierre‐Yves Le Roux, Benjamin Planquette et al. · The Lancet Oncology · 2015 · 111 citations

Medicine, Nuclear Medicine, Radiology +16

Specificity of radioiodinated MIBG for neural crest tumors in childhood.

Ann N. Leung, Brahm Shapiro, Robert S. Hattner et al. · PubMed · 1997 · 92 citations

Medicine, Nuclear Medicine, Oncology +15

Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [18F]FDG-PET tumour residual uptake at 42 Gy (RTEP7–IFCT-1402): a multicentre, randomised, controlled phase 2 trial

Pierre Véra, S. Thureau, F. Le Tinier et al. · The Lancet Oncology · 2024 · 34 citations

Medicine, Oncology, Radiation Oncology +16